WAM
ZVSAW

Wolverine Asset Management’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Wolverine Asset Management’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-230,757
Closed -$27K – 2654
2022
Q3 		$27K Sell
230,757
-1,300
-0.6% -$168 ﹤0.01% 1767
2022
Q2 		$25K Sell
232,057
-4,150
-2% -$721 ﹤0.01% 1787
2022
Q1 		$40K Buy
+236,207
New +$47.8K ﹤0.01% 1586

Wolverine Asset Management's ZVSAW Position: Q4 2022 in Review

Wolverine Asset Management sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 230,757 shares — an estimated $27K sold.

Wolverine Asset Management first reported a position in ZVSAW in Q1 2022 and held it in 3 quarters. The position peaked at $40K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • Wolverine Asset Management reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 230,757 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $27K.
  • Wolverine Asset Management first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q1 2022 and held it in 3 quarters.
  • Wolverine Asset Management's ZyVersa Therapeutics, Inc. Warrants position peaked at $40K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.